ADXS RSI Chart
Last 7 days
-50%
Last 30 days
-66.1%
Last 90 days
-69.9%
Trailing 12 Months
-56.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 522.3K | 352.5K | 182.8K | 13.0K |
2022 | 3.0M | 2.4M | 1.3M | 250.0K |
2021 | 3.7M | 3.8M | 3.8M | 3.2M |
2020 | 0 | 14.0M | 7.1M | 253.0K |
2019 | 12.0M | 15.0M | 17.9M | 20.9M |
2018 | 10.3M | 8.6M | 6.7M | 6.1M |
2017 | 7.5M | 11.0M | 14.0M | 12.0M |
2016 | 1.3M | 250.0K | 250.0K | 4.0M |
2014 | 0 | 672.3K | 836.2K | 1.0M |
2010 | 0 | 0 | 269.1K | 508.5K |
2009 | 0 | 0 | 0 | 29.7K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 07, 2024 | israel biotech fund i, l.p. | acquired | 11,138,900 | 0.4 | 27,847,200 | - |
Feb 07, 2024 | israel biotech fund i, l.p. | sold (taxes) | -6,599,580 | 1.2465 | -5,294,490 | - |
Oct 18, 2023 | amoon growth fund limited partnership | sold | - | - | - | - |
Oct 18, 2023 | israel biotech fund i, l.p. | bought | - | - | 1,317,720 | - |
Jan 19, 2023 | sidransky david | acquired | - | - | 46.00 | - |
Mar 13, 2020 | appel roni | sold | -1,320 | 0.55 | -2,401 | - |
Mar 12, 2020 | appel roni | sold | -116 | 0.58 | -200 | - |
Mar 11, 2020 | appel roni | sold | -267 | 0.67 | -399 | - |
Apr 11, 2019 | henderson molly | acquired | 9,199 | 3.6799 | 2,500 | executive vice president & cfo |
Apr 11, 2019 | gutierrez andres | acquired | 13,928 | 3.7142 | 3,750 | executive vice president & cmo |
Which funds bought or sold ADXS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | Vermillion & White Wealth Management Group, LLC | new | - | 2.00 | 2.00 | -% |
Unveiling Advaxis Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Advaxis Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Advaxis Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q4 | 2022Q3 | 2022Q3 | 2022Q2 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q4 | 2021Q3 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q4 | 2020Q3 | 2020Q2 |
Revenue | -100.0% | - | 4,500 | 9,000 | 29,500 | 50,000 | 70,500 | 91,000 | 64,500 | 38,000 | 250,000 | 500,000 | 717,500 | 935,000 | 625,000 | 250,000 | 1,375,000 | 1,615,000 | 807,500 | - | 333 | 666 |
Cost Of Revenue | - | - | - | - | - | - | - | 91,000 | - | - | - | - | - | - | 625,000 | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | 90,000 | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | - | - | - | - | - | - | 4,853,000 | - | 7,291,000 | - | 3,252,000 | - | - | 4,371,500 | - | 4,381,000 | 7,696,000 | 5,578,000 | - | 6,400,000 | 5,842,000 | 6,571,000 |
S&GA Expenses | 132.7% | 3,370,000 | 1,448,000 | 2,763,000 | 4,604,000 | - | 1,495,000 | 2,881,000 | 2,053,000 | 2,272,000 | 1,768,000 | 2,433,000 | - | 3,831,500 | 2,198,000 | 2,678,000 | 3,352,000 | 3,008,000 | - | 3,027,000 | 2,384,000 | 2,649,000 |
R&D Expenses | -4.8% | 5,410,000 | 5,683,000 | 5,723,000 | 7,265,000 | - | -10,031,000 | 7,199,000 | 2,233,000 | 5,580,000 | 1,484,000 | 7,503,000 | - | -7,352,500 | 7,368,000 | 1,703,000 | 4,344,000 | 2,570,000 | - | 3,373,000 | 3,458,000 | 3,922,000 |
EBITDA Margin | -1847.3% | -3,970 | -203 | -105 | -71.35 | -53.85 | -51.40 | -34.31 | -20.13 | -10.80 | -16.24 | -13.26 | -11.21 | -3.65 | -5.60 | -7.72 | - | - | - | - | - | - |
Income Taxes | 58.5% | 103,000 | 65,000 | 127,000 | -4,207,000 | - | -459,000 | 106,000 | -383,500 | 214,000 | 50,000 | 189,000 | - | -527,000 | 167,000 | -50,000 | - | - | - | -100,000 | - | 50,000 |
Earnings Before Taxes | -237.8% | -24,570,000 | -7,274,000 | -8,572,000 | -11,568,000 | - | 12,027,500 | -10,079,000 | -6,963,000 | -7,894,000 | -2,390,000 | -9,764,000 | - | 6,012,000 | -9,629,000 | -3,284,000 | -5,107,000 | -3,977,000 | - | -6,460,000 | -5,829,000 | -6,273,000 |
EBT Margin | -1852.4% | -3,998 | -204 | -106 | -71.67 | -54.09 | -51.63 | -34.47 | -20.23 | -10.87 | -16.31 | -13.32 | -11.26 | -3.77 | -5.69 | -7.77 | - | - | - | - | - | - |
Net Income | -236.2% | -24,673,000 | -7,339,000 | -8,699,000 | -7,361,000 | - | 12,392,000 | -10,185,000 | -6,963,000 | -8,108,000 | -2,440,000 | -9,953,000 | - | 6,359,000 | -9,796,000 | -3,334,000 | -5,107,000 | -3,977,000 | - | -6,460,000 | -5,829,000 | -6,323,000 |
Net Income Margin | -1677.8% | -3,697 | -208 | -107 | -72.79 | -54.93 | -51.46 | -34.94 | -20.57 | -11.11 | -16.63 | -13.58 | -11.48 | -3.73 | -5.75 | -7.88 | - | - | - | - | - | - |
Free Cashflow | -2.9% | -7,200,000 | -6,998,000 | -8,602,000 | -6,700,000 | 11,058,000 | 11,058,000 | 4,700,000 | 4,700,000 | 1,528,000 | 1,528,000 | -9,984,000 | 15,125,000 | 15,125,000 | -2,803,000 | -2,803,000 | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q4 | 2022Q3 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Assets | 137.5% | 16,579 | 6,981 | 12,151 | 20,995 | 7,769 | 25,930 | 14,260 | 30,101 | 37,518 | 46,498 | 41,127 | 46,780 | 51,022 | 55,771 | 45,947 | 45,828 | 38,526 | 40,019 | 45,210 | 51,348 | 45,257 |
Current Assets | 65.4% | 7,528 | 4,552 | 9,556 | 18,261 | 3,188 | 25,759 | 13,032 | 29,817 | 34,177 | 43,116 | 39,740 | 43,257 | 47,442 | 52,113 | 35,528 | 44,240 | 27,851 | 27,299 | 31,768 | 37,153 | 36,149 |
Cash Equivalents | 130.0% | 4,882 | 2,123 | 7,079 | 16,839 | 2,408 | 25,208 | 11,195 | 28,200 | 32,100 | 36,480 | 36,982 | 41,614 | 45,257 | 48,110 | 33,318 | 42,025 | 25,178 | 23,846 | 28,217 | 34,156 | 32,363 |
Net PPE | -36.1% | 540 | 845 | 882 | 950 | 960 | 38.00 | 999 | 73.00 | 84.00 | 100 | 1,120 | 118 | 278 | 333 | 2,189 | 1,283 | 2,393 | 3,667 | 3,893 | 4,121 | 4,350 |
Goodwill | - | 4,500 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Liabilities | - | - | - | - | - | - | 2,303 | - | 1,906 | 2,367 | 3,724 | - | 7,892 | 6,745 | 8,220 | 8,372 | - | 8,346 | 8,553 | 9,773 | 9,800 | 5,726 |
Current Liabilities | 193.4% | 25,018 | 8,527 | 8,427 | 9,833 | 6,201 | 2,303 | 5,705 | 1,906 | 2,367 | 3,719 | 6,472 | 7,880 | 6,745 | 8,220 | 3,577 | 6,877 | 3,291 | 3,249 | 4,225 | 4,012 | 4,521 |
Long Term Debt | 293.7% | 8,141 | 2,068 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | 293.7% | 8,141 | 2,068 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -Infinity% | -24,417 | - | 1,009 | 9,675 | -1,099 | 23,627 | 8,338 | 28,195 | 35,151 | 38,549 | 34,158 | 38,888 | 44,277 | 47,551 | 37,575 | 38,398 | 30,180 | 31,466 | 35,437 | 41,548 | 39,531 |
Retained Earnings | -14.3% | -197,200 | -172,553 | -165,214 | -156,515 | -149,154 | -442,959 | -139,600 | -438,368 | -431,405 | -428,965 | -111,141 | -428,600 | -423,156 | -419,822 | -414,715 | -70,887 | -410,738 | -404,278 | -398,449 | -392,126 | -384,269 |
Additional Paid-In Capital | 3.9% | 172,797 | 166,307 | 166,218 | 166,185 | 148,052 | 466,584 | 147,586 | 466,561 | 466,554 | 467,368 | 145,160 | 467,486 | 467,287 | 467,227 | 452,174 | 109,157 | 440,917 | 435,682 | 433,826 | 433,614 | 423,750 |
Shares Outstanding | 147.6% | 11,857 | 4,788 | 4,780 | 4,773 | 2,639 | 1,816 | 2,901 | 1,816 | 1,820 | 1,820 | - | 1,820 | 1,544 | 1,399 | - | - | - | - | - | - | - |
Float | - | - | - | 3,700 | - | - | - | - | - | 11,864 | - | - | - | - | 71,183 | - | - | - | - | 39,995 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q4 | 2022Q3 | 2022Q3 | 2022Q2 | 2022Q2 | 2022Q1 | 2022Q1 | 2021Q4 | 2021Q4 | 2021Q3 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q4 | 2020Q3 |
Cashflow From Operations | -2.9% | -7,200 | -6,998 | -8,602 | -6,700 | - | 11,058 | - | 4,700 | - | 1,528 | -9,984 | -4,138 | - | 15,125 | - | -2,803 | -6,114 | -2,786 | - | -3,218 | -5,302 |
Share Based Compensation | -195.5% | -85.00 | 89.00 | 33.00 | 1,186 | - | -1,817 | - | 25.00 | 1,375 | 23.00 | 643 | 26.00 | - | -1,398 | 1,689 | 60.00 | 215 | 236 | - | 184 | 255 |
Cashflow From Investing | - | - | - | - | - | - | 35.00 | - | -66.00 | - | -77.00 | - | -58.00 | - | -6.00 | - | -50.00 | 156 | -210 | - | -327 | -63.00 |
Cashflow From Financing | 100.0% | 4,000 | 2,000 | -1,200 | 21,201 | - | -1,468 | - | -1,000 | - | -982 | 44.00 | 4,312 | - | 2,503 | - | - | 20,750 | 11,136 | - | 4,877 | 994 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Statement [Abstract] | ||
Revenue | $ 13 | $ 692 |
Cost of Revenue | (13) | (602) |
Gross Profit | 90 | |
Research and Development | 24,081 | 27,851 |
General and Administrative | 12,185 | 9,742 |
Operating Loss | (36,266) | (37,503) |
Financial income (expenses), net | (15,718) | 74 |
Loss before taxes on income | (51,984) | (37,429) |
Taxes on Income | 3,912 | (584) |
Net Loss | $ (48,072) | $ (38,013) |
Net Loss per Share attributable to Common Stockholders, Basic | $ (7.99) | $ (13.13) |
Net Loss per Share attributable to Common Stockholders, Diluted | $ (7.99) | $ (13.13) |
Weighted Average Shares Used to Compute Net Loss per Share, Basic | 6,019,063 | 2,895,130 |
Weighted Average Shares Used to Compute Net Loss per Share, Diluted | 6,019,063 | 2,895,130 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | ||
---|---|---|---|---|
Current Assets: | ||||
Cash and Cash Equivalents | $ 4,882 | $ 2,408 | ||
Trade Receivables | 234 | |||
Prepaid Expenses and Other Current Assets | 2,646 | 546 | ||
Total Current Assets | 7,528 | 3,188 | ||
Long-Term Assets: | ||||
Deferred issuance costs | 1,953 | |||
Intangible assets, net | 3,898 | |||
Goodwill | 4,500 | |||
Operating lease right of use asset | 102 | 1,462 | ||
Property and Equipment, Net | 540 | 960 | ||
Other Assets | 11 | 206 | ||
Total Long-Term Assets | 9,051 | 4,581 | ||
Total Assets | 16,579 | 7,769 | ||
Current Liabilities: | ||||
Trade Payables | 6,076 | 4,080 | ||
Operating lease liabilities | 166 | 419 | ||
Accrued expenses and other payables | 5,554 | 708 | ||
Side Agreement and reinvestment rights | [1] | 8,436 | ||
Accrued payroll and employee benefits | 786 | 994 | ||
Proceed from Asset Sale | 4,000 | |||
Total Current Liabilities | 25,018 | 6,201 | ||
Long-Term Liabilities: | ||||
Long-term warrant liability | [1] | 6,057 | ||
Convertible Note | [1] | 8,141 | ||
Uncertain tax position | 1,771 | 1,335 | ||
Long-term operating lease liabilities | 9 | 1,332 | ||
Total Long-Term Liabilities | 15,978 | 2,667 | ||
Stockholders’ Equity: | ||||
Common Stock of $0.001 par value per share; 170,000,000 and 37,480,000* shares authorized at December 31, 2023 and 2022, respectively; 11,896,845 and 2,695,067* shares issued at December 31, 2023 and 2022, respectively; 11,857,393 and 2,638,663* shares outstanding at December 31, 2023 and 2022, Respectively. | 12 | 3 | ||
Additional Paid-in Capital | 172,797 | 148,052 | ||
Accumulated Deficit | (197,226) | (149,154) | ||
Total Stockholders’ Equity | (24,417) | (1,099) | ||
Total Liabilities and Stockholders’ Equity | $ 16,579 | $ 7,769 | ||
|